Adult Dosing
Tinea pedis (athlete’s foot)
Treatment
- Apply to the affected area(s) bid (morning and night) x 4 wks
Prevention
- Apply to the affected area(s) qd-bid (morning and night)
Tinea cruris (jock itch)
- Apply to the affected area(s) bid (morning and night) x 2 wks
Tinea corporis (ringworm)
- Apply to the affected area(s) bid (morning and night) x 4 wks
Pityriasis (tinea) versicolor
- Apply to the affected area(s) bid (morning and night)
Note:
- Wash and dry the area before application
Pediatric Dosing
Tinea pedis (athlete’s foot) [>2 yrs]
Treatment
- Apply to the affected area(s) bid (morning and night) x 4 wks
Prevention
- Apply to the affected area(s) qd-bid (morning and night)
Tinea cruris (jock itch) [>2 yrs]
- Apply to the affected area(s) bid (morning and night) x 2 wks
Tinea corporis (ringworm) [>2 yrs]
- Apply to the affected area(s) bid (morning and night) x 4 wks
Pityriasis (tinea) versicolor [>2 yrs]
- Apply to the affected area(s) bid (morning and night)
Note:
- Wash and dry the area before application
[Outline]
See Supplemental Patient Information
- Tolnaftate can cause irritation or hypersensitivity, discontinue the drug if such symptoms occurs
- If the diseases does not improve in 10 days or becomes worse, discontinue the drug and reevaluate the patient
- Unintentional or intentional concentrating and inhaling the contents of the aerosols can be harmful or fatal
- Advise patients to avoid its contact with the eye, if eye contact occurs rinse eyes thoroughly with water
Supplemental Patient Information
- Advise patient to consult their physicians if the disease does not improve within 4 wks
- Advise patient not to apply near eyes or mouth
Pregnancy Category:NR
Breastfeeding: No studies conducted on topical use of tolnaftate during breastfeeding and the extent of its absorption after topical application. Because of its poor absorption after topical application it is considered a low risk to the nursing infant. Do not apply to the nipple area and ensure that the infant's skin should not come into direct contact with the areas of skin that have been treated. Use only water-miscible cream, gel or liquid products on the breast, as ointments may expose the infant to high levels of mineral paraffins via licking. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 16 May 2011).
US Trade Name(s)
- Lamisil AF Defense Spray Powder
- Tinactin
US Availability
tolnaftate (generic)
- OTC CRE: 1%
- OTC PWDR: 1%
- OTC SOLN: 1%
Lamisil AF Defense Spray Powder
Tinactin
- OTC CRE: 1%
- OTC PWDR: 1%
- OTC SPRAY: 1%
Canadian Trade Name(s)
- Absorbine Jr Antifungal
- Athlete's Foot Gel
- Fungicure Gel
- Dr. Scholl's athlete's foot powder
- Flexitol Medicated Foot Cream
- Odor-Eaters Athlete's Foot Treatment Foot & Sneaker Spray Powder
- Proclearz Antifungal
- Pitrex
- Tinactin
- Tinactin Chill Deodorant Powder Spray
- Tinactin Chill Liquid Spray
- Von Foot Works Therapeutic Antifungal Foot
- Zeasorb AF
Canadian Availability
tolnaftate (generic)
Absorbine Jr Antifungal Liquid
Athlete's Foot Gel, Fungicure Gel
Von Foot Works Therapeutic Antifungal Foot
- OTC CRE: 1%
- OTC LIQ SPRAY: 1%
Dr. Scholl's athlete's foot powder
- OTC PWDR: 1%
- OTC PWDR SPRAY: 1%
Flexitol Medicated Foot Cream, Pitrex
Odor-Eaters Athlete's Foot Treatment Foot & Sneaker Spray Powder
Proclearz Antifungal Liquid
Tinactin
- OTC Aerosol: 10 mg/g
- OTC SPRAY: 1%
- OTC PWDR: 10 mg/g
Tinactin Chill Deodorant Powder Spray
Tinactin Chill Liquid Spray
Zeasorb AF
UK Trade Name(s)
- Dual Action Athlete's Foot Spray
- Mycil Athlete's Foot Spray
- Scholl Athlete's Foot
UK Availability
Dual Action Athlete's Foot Spray, Mycil Athlete's Foot Spray
Scholl Athlete's Foot
- CRE: 1% w/w
- PWDR: 1% w/w
- LIQ SPRAY: 0.068% w/w
Australian Trade Name(s)
- Ringworm Ointment
- Tinaderm
- Tineafax
Australian Availability
Ringworm Ointment
Tinaderm
- SOLN: 1%
- CRE: 1%
- PWDR: 1%
- PWDR SPRAY: 1%
- LIQ SPRAY: 1%
Tineafax
[Outline]